LOGIN
ID
PW
MemberShip
2025-10-27 23:54
All News
Policy
Company
Product
Opinion
InterView
°Ë»ö
Dailypharm Live Search
Close
Roche 2018 Annualreport
Roche 2018 Annualreport
2019-12-23
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2019-12-23
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
2019-11-15
Risk-Sharing Agreements in the EU: A Systematic Review
Risk-Sharing Agreements in the EU: A Systematic Review of Major Trends
2019-11-15
Managed Entry Agreements for
Managed Entry Agreements for Oncology Drugs
2019-11-15
OPINION
[Reporter's View] Transparent info, the key to vaccine trust
Reporter's view |
Son, Hyung Min
[Op-Ed] Patients, no time left for 'new drug comb therapies'
Special Contribution |
Eo, Yun-Ho
[Desk¡¯s View] Lift botulinum toxin¡¯s core tech designation
Desk's view |
Lee, Seok-Jun
INTERVIEW
"GI Innovation challenges melanoma"
"...overcoming resistance to PD-1 antibodies" says Myoung Ho Jang, CEO of GI Innovation
"New landscape in DLBCL trt¡¦Columvi¡¤Polivy's bigger role"
Professor Gareth Gregory of Monash University in Australia
"Gilead-Kite will lead the trt landscape for DLBCL in KOR"
Diego Santoro, Head of the International Region for Kite Pharma
Dong-A ST launches Sterlara biosimilar Imuldosa in the US
V-olet challenges to become a blockbuster fat-destroying inj
Kim Seul-ki, PM of Daewoong Pharmaceutical's Nabota Business Team
Data
Roche 2018 Annualreport
Roche 2018 Annualreport
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
MOST READ
1
ImmuneOncia speeds commercialization with product-fit plan
2
Ultomiris's reimb standards eased for aHUS
3
NHIS actively reviews unifying drug price-reduction system
4
"Childhood obesity is the starting point for adult diseases"
5
AstraZeneca set for leadership shift after 2 years